Literature DB >> 35716288

Review article epithelial to mesenchymal transition‑associated microRNAs in breast cancer.

Hossein Javdani1, Homa Mollaei2, Farzaneh Karimi3, Shiva Mahmoudi4, Ali Farahi5, Mohamad Javad Mirzaei-Parsa6, Arman Shahabi7,8.   

Abstract

Despite major advances, breast cancer (BC) is the most commonly diagnosed carcinoma and remains a deadly disease among women worldwide. Many researchers point toward an important role of an epithelial to mesenchymal transition (EMT) in BC development and promoting metastasis. Here, will be discussed that how functional changes of transcription factors, signaling pathways, and microRNAs (miRNA) in BC promote EMT. A thorough understanding the EMT biology can be important to determine reversing the process and design treatment approaches. There are frequent debates as to whether EMT is really relevant to BC in vivo, in which due to the intrinsic heterogeneity and tumor microenvironment. Nevertheless, given the importance of EMT in cancer progression and metastasis, the implementation of therapies against cancer-associated EMT will continue to help us develop and test potential treatments.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Epithelial-mesenchymal transition. MicroRNAs. Breast cancer. Metastasis. cancer therapy

Mesh:

Substances:

Year:  2022        PMID: 35716288     DOI: 10.1007/s11033-022-07553-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  78 in total

Review 1.  Molecular mechanisms of epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Jian Xu; Rik Derynck
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

2.  Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes.

Authors:  Mats Grände; Asa Franzen; Jan-Olof Karlsson; Lars E Ericson; Nils-Erik Heldin; Mikael Nilsson
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

Review 3.  Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.

Authors:  Wei Lu; Yibin Kang
Journal:  Dev Cell       Date:  2019-05-06       Impact factor: 12.270

4.  Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition.

Authors:  Victor D Acevedo; Rama D Gangula; Kevin W Freeman; Rile Li; Youngyou Zhang; Fen Wang; Gustavo E Ayala; Leif E Peterson; Michael Ittmann; David M Spencer
Journal:  Cancer Cell       Date:  2007-12       Impact factor: 31.743

Review 5.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

Review 6.  The role of epithelial-mesenchymal transition in cancer pathology.

Authors:  Marcello Guarino; Barbara Rubino; Gianmario Ballabio
Journal:  Pathology       Date:  2007-06       Impact factor: 5.306

Review 7.  The epithelial-mesenchymal transition: new insights in signaling, development, and disease.

Authors:  Jonathan M Lee; Shoukat Dedhar; Raghu Kalluri; Erik W Thompson
Journal:  J Cell Biol       Date:  2006-03-27       Impact factor: 10.539

8.  Dual role of E-cadherin in the regulation of invasive collective migration of mammary carcinoma cells.

Authors:  Yair Elisha; Vyacheslav Kalchenko; Yuri Kuznetsov; Benjamin Geiger
Journal:  Sci Rep       Date:  2018-03-21       Impact factor: 4.379

9.  Tumor suppressor gene E-cadherin and its role in normal and malignant cells.

Authors:  Nives Pećina-Slaus
Journal:  Cancer Cell Int       Date:  2003-10-14       Impact factor: 5.722

Review 10.  The role of miRNAs in the invasion and metastasis of cervical cancer.

Authors:  Jin-Yan Wang; Li-Juan Chen
Journal:  Biosci Rep       Date:  2019-03-15       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.